Open-label Study to Assess Immunogenicity and Safety of a Vaccine Enhancement Patch When Administered With 2 Doses of H5N1 Vaccine
Clinical trial NCT01353534 · COMPLETED
Trial details
- NCT number
- NCT01353534
- Sponsor
- Intercell USA, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2011-12-01
- Enrollment
- 276
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.